Keros Therapeutics
KROS
$57.50
Share price
-0.38%
Change (1 day)
24.81%
Change (1 year)
Categories
EPS for Keros Therapeutics (KROS)
EPS in 2023 (TTM): -$4.54
According to Keros Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.54. In 2022 the company made an earnings per share (EPS) of -$4.15 a decrease over its 2021 EPS that were of -$2.52.
EPS history for Keros Therapeutics from 2019 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.54 | 9.4% |
| 2022 | -$4.15 | 64.68% |
| 2021 | -$2.52 | 4.65% |
| 2020 | -$2.41 | 71.14% |
| 2019 | -$1.41 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -51.98% | 🇺🇸 USA |